Clinical Trials for Acute Myeloid Leukemia With KMT2A Rearrangement

Find clinical trials for acute myeloid leukemia with kmt2a rearrangement. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene

NCT ID: NCT05886049

This clinical trial, called a Phase 1 study, is exploring a new treatment option for patients who have just been diagnosed with acute myeloid leukemia (AML) that has specific genetic changes, known...

Recruiting

Phase: PHASE1 Type: interventional Locations: Oklahoma City, Oklahoma, United States, Charlottesville, Virginia, United States +17 more

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

NCT ID: NCT06222580

This clinical trial is studying two medications, SNDX-5613 and gilteritinib, to see if they can safely and effectively treat adults with a specific type of acute myeloid leukemia (AML) that has eit...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Columbus, Ohio, United States +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions